ES2002112A6 - Un metodo para preparar sales cristalinas de cefalosporinas semisinteticas, particularmente de 7-(alfa-(2-aminotiazol-4-il)-alfa-(z)-metoximinoacetamido)-3-((1-metil-1-pirrolidinio)-metil)-3-cefem-4-carboxilato - Google Patents
Un metodo para preparar sales cristalinas de cefalosporinas semisinteticas, particularmente de 7-(alfa-(2-aminotiazol-4-il)-alfa-(z)-metoximinoacetamido)-3-((1-metil-1-pirrolidinio)-metil)-3-cefem-4-carboxilatoInfo
- Publication number
- ES2002112A6 ES2002112A6 ES8600872A ES8600872A ES2002112A6 ES 2002112 A6 ES2002112 A6 ES 2002112A6 ES 8600872 A ES8600872 A ES 8600872A ES 8600872 A ES8600872 A ES 8600872A ES 2002112 A6 ES2002112 A6 ES 2002112A6
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- salts
- acid
- sulfuric acid
- addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
UN METODO PARA PREPARAR SALES CRISTALINAS DE CEFALOSPORINAS SEMISINTETICAS, PARTICULARMENTE 7-A-(2-AMINOTIAZOL-4-IL)-A-(Z)-METOXIMINOACETAMIDO-3-(1-METIL-1-PIRROLIDINIO)-METIL-3-CEFEM-4-CARBOXILATO. LAS SALES DE ADICION DE ACIDO SULFURICO, DI-NITRICO, MONO-CLORHIDRICO, DI-CLORHIDRICO Y DI- Y SESQUI-ORTOFOSFORICO DEL 7A-(2 AMINOTIZAOL-4-IL)-A-(Z)-METOXIMINOACETAMIDO-3-(1-METIL-PIRROLIDINIO)-METIL-3-CEFEM-4-CARBOXILATO, CRISTALINAS, SON ESTABLES INCLUSO A TEMPERATURAS ELEVADAS. LA SAL DE ADICION DE ACIDO SULFURICO CRISTALINA SE PREPARA MEDIANTE LA FORMACION DE UNA MEZCLA DE (A) AL MENOS UN EQUIVALENTE MOLAR DE ACIDO SULFURICO CON (B) EL ZWITTERION EN UNA CANTIDAD TAL QUE ESTE PRESENTE EN LA MEZCLA A UNA CONCENTRACION MAYOR DE 25 MG/ML, EL PROVOCAR Y LA CRISTALIZACION, LA SEPARACION DE LOS CRISTALES, EL LAVADO Y SECADO. LAS SALES CRISTALINAS MONOCLORHIDRATO, DI-CLORHIDRATO- Y ORTOFOSFATO SE PREPARAN POR DISOLUCION DEL ZWITTERION EN LA CANTIDAD ADECUADA DE ACIDO, PROVOCANDO LA CRISTALIZACION POR ADICION DE ACETONA Y AISLANDO LOS CRISTALES. LAS MEZCLAS FISICAS DE LAS SALES CON ALGUNS BASES, EN PROPORCIONES QUE DEN PH ENTRE 3, 5 Y 7 AL DILUIR CON AGUA, PROPORCIONAN COMPOSICIONES INYECTABLES AL DILUIR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76223585A | 1985-08-05 | 1985-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2002112A6 true ES2002112A6 (es) | 1988-07-16 |
Family
ID=25064475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8600872A Expired ES2002112A6 (es) | 1985-08-05 | 1986-08-05 | Un metodo para preparar sales cristalinas de cefalosporinas semisinteticas, particularmente de 7-(alfa-(2-aminotiazol-4-il)-alfa-(z)-metoximinoacetamido)-3-((1-metil-1-pirrolidinio)-metil)-3-cefem-4-carboxilato |
Country Status (34)
Country | Link |
---|---|
JP (1) | JPH0615548B2 (es) |
KR (1) | KR930003121B1 (es) |
AR (1) | AR243894A1 (es) |
AT (1) | AT390957B (es) |
AU (1) | AU597262B2 (es) |
BE (1) | BE905219A (es) |
CA (1) | CA1284994C (es) |
CH (1) | CH675581A5 (es) |
CS (2) | CS276717B6 (es) |
CY (1) | CY1614A (es) |
DD (2) | DD254941A5 (es) |
DE (1) | DE3626375A1 (es) |
DK (1) | DK162053C (es) |
EG (1) | EG18003A (es) |
ES (1) | ES2002112A6 (es) |
FI (1) | FI84484C (es) |
FR (1) | FR2585705B1 (es) |
GB (1) | GB2179936B (es) |
GR (1) | GR862055B (es) |
HK (1) | HK99691A (es) |
HU (1) | HU196602B (es) |
IE (1) | IE59222B1 (es) |
IL (1) | IL79608A (es) |
IT (1) | IT1197067B (es) |
LU (2) | LU86540A1 (es) |
MY (1) | MY102212A (es) |
NL (1) | NL8601991A (es) |
OA (1) | OA08672A (es) |
PT (1) | PT83134B (es) |
SE (1) | SE469633B (es) |
SG (1) | SG79791G (es) |
SU (1) | SU1516013A3 (es) |
YU (1) | YU45793B (es) |
ZA (1) | ZA865842B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883868A (en) * | 1984-12-27 | 1989-11-28 | Banyu Pharmaceutical Co., Ltd. | 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives |
WO1988010263A1 (en) * | 1987-06-25 | 1988-12-29 | Banyu Pharmaceutical Co., Ltd. | Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation |
US4959469A (en) * | 1984-12-27 | 1990-09-25 | Banyu Pharmaceutical Company, Ltd. | Crystalline cephalosporin compounds |
US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
JPH02101081A (ja) * | 1988-10-08 | 1990-04-12 | Meiji Seika Kaisha Ltd | セファロスポリン誘導体結晶性二塩酸塩及びその製造法 |
CA2011116C (en) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Lyophilized bmy-28142 dihydrochloride for parenteral use |
CA2101571A1 (en) * | 1992-09-08 | 1994-03-09 | Elizabeth A. Garofalo | Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
EP0638573A1 (en) * | 1993-08-10 | 1995-02-15 | Lucky Ltd. | Crystalline hydrates of cephalosporin and process for preparation thereof |
JP4616844B2 (ja) | 2003-12-23 | 2011-01-19 | サンド・ゲーエムベーハー | セファロスポリン合成に使用するための中間体の生成プロセス |
WO2008056221A2 (en) * | 2006-11-06 | 2008-05-15 | Orchid Chemicals & Pharmaceuticals Limited | Crystalline sulfate salt of cephalosporin antibiotic |
DE102012101680A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151588A (en) * | 1979-05-14 | 1980-11-26 | Takeda Chem Ind Ltd | Preparation of cephalosporin salt crystal |
US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
CA1213882A (en) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporins |
US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
DE3419015A1 (de) * | 1984-05-22 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von cephalosporinen |
GB8424692D0 (en) * | 1984-10-01 | 1984-11-07 | Glaxo Group Ltd | Chemical compounds |
GB2165245B (en) * | 1984-10-01 | 1988-05-25 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-07-28 CA CA000514766A patent/CA1284994C/en not_active Expired - Lifetime
- 1986-07-28 FR FR8610892A patent/FR2585705B1/fr not_active Expired
- 1986-07-29 AR AR86304717A patent/AR243894A1/es active
- 1986-07-30 AU AU60694/86A patent/AU597262B2/en not_active Expired
- 1986-07-31 YU YU137186A patent/YU45793B/sh unknown
- 1986-08-01 FI FI863155A patent/FI84484C/fi not_active IP Right Cessation
- 1986-08-01 IE IE207886A patent/IE59222B1/en not_active IP Right Cessation
- 1986-08-04 SE SE8603308A patent/SE469633B/sv not_active IP Right Cessation
- 1986-08-04 ZA ZA865842A patent/ZA865842B/xx unknown
- 1986-08-04 NL NL8601991A patent/NL8601991A/nl not_active Application Discontinuation
- 1986-08-04 BE BE07217010A patent/BE905219A/fr not_active IP Right Cessation
- 1986-08-04 SU SU864027914A patent/SU1516013A3/ru active
- 1986-08-04 LU LU86540A patent/LU86540A1/fr unknown
- 1986-08-04 JP JP61183288A patent/JPH0615548B2/ja not_active Expired - Lifetime
- 1986-08-04 IL IL79608A patent/IL79608A/xx not_active IP Right Cessation
- 1986-08-04 IT IT21409/86A patent/IT1197067B/it active Protection Beyond IP Right Term
- 1986-08-04 CH CH3117/86A patent/CH675581A5/de not_active IP Right Cessation
- 1986-08-04 DK DK371886A patent/DK162053C/da not_active IP Right Cessation
- 1986-08-04 GR GR862055A patent/GR862055B/el unknown
- 1986-08-04 CS CS865827A patent/CS276717B6/cs unknown
- 1986-08-04 PT PT83134A patent/PT83134B/pt unknown
- 1986-08-04 GB GB8618989A patent/GB2179936B/en not_active Expired
- 1986-08-04 LU LU88574C patent/LU88574I2/fr unknown
- 1986-08-04 CS CS903570A patent/CS276849B6/cs unknown
- 1986-08-04 DE DE19863626375 patent/DE3626375A1/de not_active Ceased
- 1986-08-05 AT AT0211086A patent/AT390957B/de not_active IP Right Cessation
- 1986-08-05 KR KR1019860006445A patent/KR930003121B1/ko not_active IP Right Cessation
- 1986-08-05 DD DD86293433A patent/DD254941A5/de unknown
- 1986-08-05 HU HU863376A patent/HU196602B/hu unknown
- 1986-08-05 ES ES8600872A patent/ES2002112A6/es not_active Expired
- 1986-08-05 OA OA58918A patent/OA08672A/xx unknown
-
1987
- 1987-09-29 MY MYPI87002279A patent/MY102212A/en unknown
-
1988
- 1988-03-30 DD DD88314213A patent/DD268395A5/de unknown
-
1989
- 1989-08-04 EG EG489/86A patent/EG18003A/xx active
-
1991
- 1991-10-02 SG SG797/91A patent/SG79791G/en unknown
- 1991-12-05 HK HK996/91A patent/HK99691A/xx not_active IP Right Cessation
-
1992
- 1992-07-10 CY CY1614A patent/CY1614A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2012948A6 (es) | Procedimiento para la preparacion de sales de cefalosporina y composiciones inyectables | |
ES2002112A6 (es) | Un metodo para preparar sales cristalinas de cefalosporinas semisinteticas, particularmente de 7-(alfa-(2-aminotiazol-4-il)-alfa-(z)-metoximinoacetamido)-3-((1-metil-1-pirrolidinio)-metil)-3-cefem-4-carboxilato | |
GB1409693A (en) | Triazolobenzodiazepines | |
SE8304045L (sv) | Derivat av morfolinyl-daunorubicin och morfolinyl-doxorubicin, och analoger derav samt forfarande for framstellning derav | |
PT84491B (pt) | Processo de preparacao de sulfato de dermatano de alta pureza, e de composicoes farmaceuticas que o contem | |
AR248407A1 (es) | Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina. | |
SE8800036L (sv) | Lyofiliserad eller felld kombination cefalosporin-zwitterjon och salt | |
DE3863859D1 (de) | Stabile, injizierbare loesungen von salzen von vincristin. | |
EP0386668B1 (en) | Lyophilized dihydrochloride of 7-[alpha-(2-aminothiazol-4-yl)-alpha-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)-methyl]-3-cephem-4-carboxylate | |
US4235900A (en) | Cephradine compositions | |
ATE114714T1 (de) | Verfahren zur kristallisation von subtilisin. | |
MY116452A (en) | Cephalosporin salts and injectable compositions | |
SE7608049L (sv) | Nya apovinkaminolderivat jemte sett for deras framstellning | |
GB1162247A (en) | Cephalosporanic Acid Derivatives and a Process for the Preparation thereof | |
FR2444042A1 (fr) | Sel cristallin de derives de la cephalosporine, son procede de preparation et composition antibiotique renfermant ce sel | |
FR2553418B1 (fr) | Derives d'acides (oxo carbonamido heterocyclique) cephem carboxyliques a proprietes antibacteriennes | |
Grist et al. | Evidence for a Halothane‐Dependent Cyclic Flux of Calcium in Rat‐Liver Mitochondria | |
US4680389A (en) | Temperature stable crystalline di(1-methyl-2-pyrralidinone) and di(N-formylpyrrolidine) adducts of cephalosporin derivatives | |
GB1513322A (en) | Heterocyclic ergoline derivatives | |
JPS57149229A (en) | Frozen fibrinogen preparation | |
JPS53144594A (en) | 3,7-di-substitued-3-cephem-4-carboxylic acid derivatives | |
ES424362A1 (es) | Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente. | |
JPS5325590A (en) | 7-(n-substituted alkanoyl-2-phenylglycineamide)-cephalosporanic acid derivatives | |
GB1382435A (en) | Free flowing epicillin | |
JPS57131795A (en) | Novel cephem compound and salt thereof, preparation of the same and preventing agent and remedy for microbism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20060807 |